The R&D expense increase rate of pharmaceutical companies in KOSPI was 3 times higher than the one for the KOSDAQ

It was estimated that R&D expenses of KOSPI and KODAQ listed pharmaceutical companies increased respective 16.5% and 5.4% up in the first half compared to the same half of the year.

Pharmaceutical companies listed in the KOSPI = According to the YakupDotCom’s(www.yakup.com) analysis result for the ‘Top 5’ of 35 KOSPI listed pharmaceutical companies in the amount of R&D expenses, Hanmi Pharm re...